Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-α and neutrophil elastase

Tadashi Kohyama, Xiang-de Liu, Kui Zhu Yun, Fu Qiang Wen, Jun Wang Hang, Qiuhong Fang, Tetsu Kobayashi, Stephen I. Rennard

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Tissue destruction, resulting in emphysema, can be a consequence of several pathologic processes. The current study evaluated the effects of the phosphodiesterase (PDE)4 inhibitor, cilomilast, and other PDE inhibitors on the ability of fibroblasts to degrade extracellular matrix. Using the three-dimensional collagen gel culture system, fibroblasts (HFL-1) were cultured with tumor necrosis factor (TNF)-α, known to induce matrix metalloproteinase (MMP) release, and/or neutrophil elastase (NE), which can induce MMP activation. On Day 4, gels containing TNF-α and NE were significantly degraded (20.8 ± 2.9% of original collagen content). Cilomilast (10 μM) inhibited this degradation (84.4 ± 8.4%). Amrinone, a PDE3 inhibitor, and zaprinast, a PDE5 inhibitor, had no effect. Gelatin zymography and immunoblotting revealed that fibroblasts cultured with TNF-α released increased amounts of latent MMP-1 and -9. The addition of NE resulted in the conversion of MMP-1 and -9 to their active forms, indicative of collagen degradation. Cilomilast inhibited the release of MMP-1 and -9, as well as conversion of MMP-1 to its active form. Using real-time PCR analysis, cilomilast's effect on MMP-1 release was not associated with the proteinase's mRNA expression, suggesting that the inhibition of release is regulated at the post-transcriptional level. These results suggest that cilomilast may be a potentially effective therapeutic agent in diseases characterized by excessive tissue destruction, such as emphysema.

Original languageEnglish (US)
Pages (from-to)487-494
Number of pages8
JournalAmerican journal of respiratory cell and molecular biology
Volume27
Issue number4
DOIs
StatePublished - Oct 2002

Fingerprint

Phosphodiesterase 4 Inhibitors
Leukocyte Elastase
Matrix Metalloproteinase 1
Fibroblasts
Collagen
Tumor Necrosis Factor-alpha
Gels
Matrix Metalloproteinase 9
Degradation
Emphysema
Matrix Metalloproteinases
Matrix Metalloproteinase 12
Phosphodiesterase 3 Inhibitors
Amrinone
Tissue
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Pathologic Processes
Gelatin
Cell culture

ASJC Scopus subject areas

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-α and neutrophil elastase. / Kohyama, Tadashi; Liu, Xiang-de; Yun, Kui Zhu; Wen, Fu Qiang; Hang, Jun Wang; Fang, Qiuhong; Kobayashi, Tetsu; Rennard, Stephen I.

In: American journal of respiratory cell and molecular biology, Vol. 27, No. 4, 10.2002, p. 487-494.

Research output: Contribution to journalArticle

Kohyama, Tadashi ; Liu, Xiang-de ; Yun, Kui Zhu ; Wen, Fu Qiang ; Hang, Jun Wang ; Fang, Qiuhong ; Kobayashi, Tetsu ; Rennard, Stephen I. / Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-α and neutrophil elastase. In: American journal of respiratory cell and molecular biology. 2002 ; Vol. 27, No. 4. pp. 487-494.
@article{4bd85c099fac4b8698f24e754b662d77,
title = "Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-α and neutrophil elastase",
abstract = "Tissue destruction, resulting in emphysema, can be a consequence of several pathologic processes. The current study evaluated the effects of the phosphodiesterase (PDE)4 inhibitor, cilomilast, and other PDE inhibitors on the ability of fibroblasts to degrade extracellular matrix. Using the three-dimensional collagen gel culture system, fibroblasts (HFL-1) were cultured with tumor necrosis factor (TNF)-α, known to induce matrix metalloproteinase (MMP) release, and/or neutrophil elastase (NE), which can induce MMP activation. On Day 4, gels containing TNF-α and NE were significantly degraded (20.8 ± 2.9{\%} of original collagen content). Cilomilast (10 μM) inhibited this degradation (84.4 ± 8.4{\%}). Amrinone, a PDE3 inhibitor, and zaprinast, a PDE5 inhibitor, had no effect. Gelatin zymography and immunoblotting revealed that fibroblasts cultured with TNF-α released increased amounts of latent MMP-1 and -9. The addition of NE resulted in the conversion of MMP-1 and -9 to their active forms, indicative of collagen degradation. Cilomilast inhibited the release of MMP-1 and -9, as well as conversion of MMP-1 to its active form. Using real-time PCR analysis, cilomilast's effect on MMP-1 release was not associated with the proteinase's mRNA expression, suggesting that the inhibition of release is regulated at the post-transcriptional level. These results suggest that cilomilast may be a potentially effective therapeutic agent in diseases characterized by excessive tissue destruction, such as emphysema.",
author = "Tadashi Kohyama and Xiang-de Liu and Yun, {Kui Zhu} and Wen, {Fu Qiang} and Hang, {Jun Wang} and Qiuhong Fang and Tetsu Kobayashi and Rennard, {Stephen I.}",
year = "2002",
month = "10",
doi = "10.1165/rcmb.4818",
language = "English (US)",
volume = "27",
pages = "487--494",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-α and neutrophil elastase

AU - Kohyama, Tadashi

AU - Liu, Xiang-de

AU - Yun, Kui Zhu

AU - Wen, Fu Qiang

AU - Hang, Jun Wang

AU - Fang, Qiuhong

AU - Kobayashi, Tetsu

AU - Rennard, Stephen I.

PY - 2002/10

Y1 - 2002/10

N2 - Tissue destruction, resulting in emphysema, can be a consequence of several pathologic processes. The current study evaluated the effects of the phosphodiesterase (PDE)4 inhibitor, cilomilast, and other PDE inhibitors on the ability of fibroblasts to degrade extracellular matrix. Using the three-dimensional collagen gel culture system, fibroblasts (HFL-1) were cultured with tumor necrosis factor (TNF)-α, known to induce matrix metalloproteinase (MMP) release, and/or neutrophil elastase (NE), which can induce MMP activation. On Day 4, gels containing TNF-α and NE were significantly degraded (20.8 ± 2.9% of original collagen content). Cilomilast (10 μM) inhibited this degradation (84.4 ± 8.4%). Amrinone, a PDE3 inhibitor, and zaprinast, a PDE5 inhibitor, had no effect. Gelatin zymography and immunoblotting revealed that fibroblasts cultured with TNF-α released increased amounts of latent MMP-1 and -9. The addition of NE resulted in the conversion of MMP-1 and -9 to their active forms, indicative of collagen degradation. Cilomilast inhibited the release of MMP-1 and -9, as well as conversion of MMP-1 to its active form. Using real-time PCR analysis, cilomilast's effect on MMP-1 release was not associated with the proteinase's mRNA expression, suggesting that the inhibition of release is regulated at the post-transcriptional level. These results suggest that cilomilast may be a potentially effective therapeutic agent in diseases characterized by excessive tissue destruction, such as emphysema.

AB - Tissue destruction, resulting in emphysema, can be a consequence of several pathologic processes. The current study evaluated the effects of the phosphodiesterase (PDE)4 inhibitor, cilomilast, and other PDE inhibitors on the ability of fibroblasts to degrade extracellular matrix. Using the three-dimensional collagen gel culture system, fibroblasts (HFL-1) were cultured with tumor necrosis factor (TNF)-α, known to induce matrix metalloproteinase (MMP) release, and/or neutrophil elastase (NE), which can induce MMP activation. On Day 4, gels containing TNF-α and NE were significantly degraded (20.8 ± 2.9% of original collagen content). Cilomilast (10 μM) inhibited this degradation (84.4 ± 8.4%). Amrinone, a PDE3 inhibitor, and zaprinast, a PDE5 inhibitor, had no effect. Gelatin zymography and immunoblotting revealed that fibroblasts cultured with TNF-α released increased amounts of latent MMP-1 and -9. The addition of NE resulted in the conversion of MMP-1 and -9 to their active forms, indicative of collagen degradation. Cilomilast inhibited the release of MMP-1 and -9, as well as conversion of MMP-1 to its active form. Using real-time PCR analysis, cilomilast's effect on MMP-1 release was not associated with the proteinase's mRNA expression, suggesting that the inhibition of release is regulated at the post-transcriptional level. These results suggest that cilomilast may be a potentially effective therapeutic agent in diseases characterized by excessive tissue destruction, such as emphysema.

UR - http://www.scopus.com/inward/record.url?scp=0036787848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036787848&partnerID=8YFLogxK

U2 - 10.1165/rcmb.4818

DO - 10.1165/rcmb.4818

M3 - Article

C2 - 12356583

AN - SCOPUS:0036787848

VL - 27

SP - 487

EP - 494

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 4

ER -